China to cut cancer drug prices; Nimbus nabs Gilead's Adrian Ray to serve as SVP of discovery biology
→ China’s medical insurance authorities are pledging to slash cancer drug prices, according to a weekend report from the Communist party-run People’s Daily. Drugs already …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.